NasdaqGS - Delayed Quote ? USD Seer, Inc. (SEER) Follow Compare 1.9800 +0.0100 (+0.51%) At close: October 16 at 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Seer Inc (SEER) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges Amid Strategic ... Seer Inc (SEER) reports a 23% revenue decline but strengthens its market presence with new initiatives and a robust cash position. GuruFocus.com ? 7 days ago SEER +0.51% Seer, Inc. (NASDAQ:SEER) has caught the attention of institutional investors who hold a sizeable 50% stake Key Insights Given the large stake in the stock by institutions, Seer's stock price might be vulnerable to their... Simply Wall St. ? 20 days ago SEER +0.51% Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY. Seer’s management is scheduled to participate in a fireside chat on Thursday, September 5th at 4:05 p.m. Eastern Time / 1:05 p.m. Pacific Time. A live webcast of the session will be a GlobeNewswire ? last month SEER +0.51% Seer, Inc. (NASDAQ:SEER) Analysts Just Slashed This Year's Revenue Estimates By 18% Today is shaping up negative for Seer, Inc. ( NASDAQ:SEER ) shareholders, with the analysts delivering a substantial... Simply Wall St. ? last month SEER +0.51% Seer Appoints Nicolas Roelofs to its Board of Directors REDWOOD CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading healthcare, life science tools, and diagnostics companies,” said Omid Farokhzad, Chair and CEO of Seer. “His exte GlobeNewswire ? 2 months ago SEER +0.51% US$7.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results Seer, Inc. ( NASDAQ:SEER ) investors will be delighted, with the company turning in some strong numbers with its latest... Simply Wall St. ? 2 months ago SEER +0.51% Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 44th Annual Growth Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat on Wednesday, August 14th at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the session will be available o GlobeNewswire ? 2 months ago SEER +0.51% Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates Seer (SEER) delivered earnings and revenue surprises of 2.78% and 7.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago SEER +0.51% Seer Reports Second Quarter 2024 Financial Results Launched STAC in Europe and additional customer papers published in leading journalsREDWOOD CITY, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Achieved revenue of $3.1 million for the second quarter of 2024Launched the Seer Technology Access Center (STAC) in Europe, providing researchers wi GlobeNewswire ? 2 months ago SEER +0.51% Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at investor. GlobeNewswire ? 2 months ago SEER +0.51% Will Seer (NASDAQ:SEER) Spend Its Cash Wisely? Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and... Simply Wall St. ? 3 months ago SEER +0.51% Seer Proteograph? Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CITY, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced three publications highlighting studies l GlobeNewswire ? 4 months ago SEER +0.51% Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study Combined Workflow of Proteograph? XT Assay and Thermo Scientific? Orbitrap? Astral? Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 SubjectsREDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to date utilizing the Seer GlobeNewswire ? 4 months ago SEER +0.51% Seer Inc (SEER) Q1 2024 Earnings: Revenue Declines but Losses Narrow, Meeting Some Analyst ... Insights into Seer Inc's First Quarter Financial Performance GuruFocus.com ? 5 months ago SEER +0.51% Seer First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag Seer ( NASDAQ:SEER ) First Quarter 2024 Results Key Financial Results Revenue: US$3.07m (down 24% from 1Q 2023). Net... Simply Wall St. ? 5 months ago SEER +0.51% Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript May 8, 2024 Seer, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the Seer, Inc. First Quarter 2024 Earnings Conference Call. […] Insider Monkey ? 5 months ago SEER +0.51% Q1 2024 Seer Inc Earnings Call Q1 2024 Seer Inc Earnings Call Thomson Reuters StreetEvents ? 5 months ago SEER +0.51% Seer Inc (SEER) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... Despite a revenue dip, Seer Inc outlines strategic initiatives and a $25 million share repurchase program to bolster long-term growth. GuruFocus.com ? 5 months ago SEER +0.51% Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates Seer (SEER) delivered earnings and revenue surprises of -3.23% and 13.51%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 5 months ago SEER +0.51% Seer Reports First Quarter 2024 Financial Results Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publicationsREDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Achieved revenue of $3.1 million for the first quarter of 2024Announced the expansion of the Seer Technology Acce GlobeNewswire ? 5 months ago SEER +0.51% Performance Overview Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return SEER S&P 500 YTD +2.06% +22.49% 1-Year +9.39% +35.00% 3-Year -94.00% +30.66%
